Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2020-11-02 | Welltok | Series E - IV | $5M | Bessemer Venture Partners, Canaan Partners, Emergence Capital Partners, and New Enterprise Associates |
2020-07-27 | Welltok | Series E - III | $10.44M | Bessemer Venture Partners, Canaan Partners, Emergence Capital Partners, and New Enterprise Associates |
2019-11-13 | PMV Pharmaceuticals | Series C | $62M | Boxer Capital, Euclidean Capital, Nextech Invest, OrbiMed Advisors, Osage University Partners, Topspin Consumer Partners, and Viking Global Investors |
2019-08-07 | Sera Prognostics | Series D | $36M | Blue Ox Capital, Catalyst Health Ventures, Chione, Domain Associates, LabCorp, and Upstart Venture |
2019-07-11 | NewsCred | Series F | Dentsu Group, FirstMark Capital, FTV Capital, Greycroft, and Mayfield Fund |